• Stereotaktische Radiotherapie in Lunge und Leber
• LDR Brachytherapie der Prostata
• Gastro-Intestinale Tumoren
  

Medizinstudium Universität Köln und Heidelberg.

Deutsch, Englisch

Amerikanische Gesellschaft für Radioonkologie (ASTRO)

Europäische Gesellschaft für Radioonkologie (ESTRO)

Deutsche Gesellschaft für Radioonkologie (DEGRO)

Deutsche Krebsgesellschaft (DKG)

Schweizerische Ärztegesellschaft FMH

Wulf, J., Hädinger, U., Oppitz, U., Thiele, W., Müller, G., Flentje, M.: Stereotactic radiotherapy of primary lung cancer and pulmonary metastases: a non-invasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60(1): 186-196; 2004.

Wulf, J., Guckenberger, M., Hädinger, U., Oppitz, U., Mueller, G., Baier, K., Flentje, M.: Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45(7): 838-47; 2006.

Vordermark, D., Wulf, J., Markert, K., Baier, K., Koelbl, O., Beckmann, G., Bratengeier, K., Noe, M., Schoen, G., Flentje, M.: 3D-conformal treatment of prostate-cancer to 74Gy versus high-dose-rate brachytherapy boost: A cross-sectional quality-of-life survey. Acta Oncol 45: 708-16; 2006

Vordermark, D., Lackenbauer, A., Wulf, J., Guckenberger, M., Flentje, M.: Local control in 118 consecutive high-risk breast cancer patients treated with breast conserving therapy. Oncol Rep 18(5):1335-9; 2007.

Dunst, J., Debus, J., Rudat, V., Wulf, J., Budach, W., Hoelscher, T., Reese, T., Mose, S., Roedel, C., Zuehlke, H., Hinke, A.: Neoadjuvant capecetabine combined with standard radiotherapy in patients with advanced rectal cancer: mature results of a phase II trial. Strahlenther Onkol 184(9):450-6; 2008.

Vordermark, D., Noe, M., Markert, K., Wulf, J., Müller, G., Bratengeier, K., Beckmann, G., Baier, F., Guckenberger, M., Schiefelbein, F., Schön, G., Flentje, M., Baier, K.: Prospective evaluation of quality of life after permanant prostate brachytherapy with I-125: importance of baseline symptoms and of prostate V-150. Radiother Oncol 91(2):217-24; 2009.

Guckenberger, M., Wulf, J., Thalheimer, A., Wehner, D., Thiede, A., Müller, G., Sailer, M., Flentje, M.: Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy – long term results. Radiat Oncol 4:67; 2009.

Nagata, Y., Timmerman, R., Lax, I., Wulf, J., Zimmermann, F., Jeremic, B.: Stereotactic radiotherapy of primary lung cancer and other targets. Results of consultant meeting of the International Atomic Energy Agency (IAEA). . Int J Radiat Oncol Biol Phys 79 (3): 660-9; 2011.